✉news HealthMedicine first seen 5 h ago, last 55 min ago, peak #10
Penn Medicine and IBA Launch Global Proton Therapy Venture
Original: Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
Penn Medicine and IBA have announced a joint venture aimed at advancing proton therapy and radiation oncology program development worldwide. The partnership will combine the University of Pennsylvania health system's clinical expertise with the Belgian company's proton therapy technology to help institutions globally develop advanced cancer treatment programs. The news was picked up by international outlets including The Manila Times, reflecting interest in the global expansion of this cancer care technology.
Why now: The newly announced joint venture pairs a leading US academic health system with a major proton therapy equipment maker, drawing attention to the worldwide expansion of advanced cancer treatment.
Penn MedicineIBAUniversity of Pennsylvania
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 55 min ago.
Evidence
- Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide · Yahoo Finance
- Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide · The Manila Times
API: https://socialmediatrends-api.osmike.com/v1/trends/201178